These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 28131133)

  • 21. The role of teriparatide in sequential and combination therapy of osteoporosis.
    Meier C; Lamy O; Krieg MA; Mellinghoff HU; Felder M; Ferrari S; Rizzoli R
    Swiss Med Wkly; 2014; 144():w13952. PubMed ID: 24896070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination and sequential treatment in women with postmenopausal osteoporosis.
    Anastasilakis AD; Polyzos SA; Yavropoulou MP; Makras P
    Expert Opin Pharmacother; 2020 Mar; 21(4):477-490. PubMed ID: 31990595
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug-Related Adverse Events of Osteoporosis Therapy.
    Khan M; Cheung AM; Khan AA
    Endocrinol Metab Clin North Am; 2017 Mar; 46(1):181-192. PubMed ID: 28131131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anabolic skeletal therapy for osteoporosis.
    Girotra M; Rubin MR; Bilezikian JP
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):745-54. PubMed ID: 17117299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential Effects of Teriparatide and Denosumab on Intact PTH and Bone Formation Indices: AVA Osteoporosis Study.
    Dempster DW; Zhou H; Recker RR; Brown JP; Recknor CP; Lewiecki EM; Miller PD; Rao SD; Kendler DL; Lindsay R; Krege JH; Alam J; Taylor KA; Janos B; Ruff VA
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1353-63. PubMed ID: 26859106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Individualizing osteoporosis therapy.
    Silverman S; Christiansen C
    Osteoporos Int; 2012 Mar; 23(3):797-809. PubMed ID: 22218417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone density after teriparatide in patients with or without prior antiresorptive treatment: one-year results from the EUROFORS study.
    Minne H; Audran M; Simões ME; Obermayer-Pietsch B; Sigurðsson G; Marín F; Dalsky GP; Nickelsen T;
    Curr Med Res Opin; 2008 Nov; 24(11):3117-28. PubMed ID: 18838053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An overview of the management of osteoporosis in the aging female population.
    Amin U; McPartland A; O'Sullivan M; Silke C
    Womens Health (Lond); 2023; 19():17455057231176655. PubMed ID: 37218715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study).
    Tsai JN; Uihlein AV; Burnett-Bowie SM; Neer RM; Derrico NP; Lee H; Bouxsein ML; Leder BZ
    J Clin Endocrinol Metab; 2016 May; 101(5):2023-30. PubMed ID: 26964731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium].
    Uebelhart D; Frey D; Frey-Rindova P; Goerres G; Michel BA
    Z Rheumatol; 2003 Dec; 62(6):512-7. PubMed ID: 14685711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteoanabolic therapy for osteoporosis in women.
    McClung MR; Clark AL
    Climacteric; 2022 Feb; 25(1):60-66. PubMed ID: 34342243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrence of bilateral atypical femoral fractures associated with the sequential use of teriparatide and denosumab: a case report.
    Ramchand SK; Chiang CY; Zebaze RM; Seeman E
    Osteoporos Int; 2016 Feb; 27(2):821-5. PubMed ID: 26458389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between teriparatide and bisphosphonates for improving bone mineral density in postmenopausal osteoporosis patients: A meta-analysis.
    Fan G; Zhao Q; Lu P; Chen H; Tan W; Guo W; Liu C; Liu J
    Medicine (Baltimore); 2020 Apr; 99(15):e18964. PubMed ID: 32282692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anabolic agents: a new chapter in the management of osteoporosis.
    Khan AW; Khan A
    J Obstet Gynaecol Can; 2006 Feb; 28(2):136-41. PubMed ID: 16643716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Different Perspectives of Drug Holiday and Combination Therapies When Treating Osteoporosis].
    Oser S; Häuselmann HJ
    Praxis (Bern 1994); 2021; 110(16):975-983. PubMed ID: 34875857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination therapy for treatment of osteoporosis: A review.
    Pinkerton JV; Dalkin AC
    Am J Obstet Gynecol; 2007 Dec; 197(6):559-65. PubMed ID: 18060937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination therapy of anabolic and nonbisphosphonates antiresorptive agents for the treatment of osteoporosis: A meta-analysis.
    Lou S; Wang L; Wang Y; Jiang Y; Liu J; Wang Y
    Medicine (Baltimore); 2017 Dec; 96(52):e9534. PubMed ID: 29384970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe low turnover osteoporosis.
    Pietrogrande L
    Aging Clin Exp Res; 2007 Aug; 19(4 Suppl):26-9. PubMed ID: 18182889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequential treatment of severe postmenopausal osteoporosis after teriparatide: final results of the randomized, controlled European Study of Forsteo (EUROFORS).
    Eastell R; Nickelsen T; Marin F; Barker C; Hadji P; Farrerons J; Audran M; Boonen S; Brixen K; Gomes JM; Obermayer-Pietsch B; Avramidis A; Sigurdsson G; Glüer CC
    J Bone Miner Res; 2009 Apr; 24(4):726-36. PubMed ID: 19049337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postmenopausal osteoporosis.
    Diab DL; Watts NB
    Curr Opin Endocrinol Diabetes Obes; 2013 Dec; 20(6):501-9. PubMed ID: 24150190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.